To improve and develop our monotherapeutic approach for Helicobacter pylori infection, some Schiff base compounds containing eugenol and guaiacol were synthesized and their antioxidant capacities, urease enzyme inhibition, and Anti-Helicobacter pylori effect were investigated and compared with azo analogs in the literature. All Schiff base compounds have been found to have both stronger urease enzyme inhibitory and more effective Anti-Helicobacter pylori properties than its azo analogs. In particular, the antimicrobial effect of Schiff bases containing eugenol increased dramatically when compared to their azo analogs.
Similar content being viewed by others
References
J. R. Warren, Lancet, 1, 1273 – 1273 (1983).
B. J. Marshall, Am. J. Gastroenterol., 89, S116 – S128 (1994).
M. R. Amieva and E. M. El-Omar, Gastroenterol., 134, 306 – 323 (2008).
D. A. Watson, Clin. Infect. Dis., 36, 127 – 127 (2003).
F. Megraud and P. Lehours, Clin. Microbiol. Rev., 20, 280 (2007).
A. O’Connor, J. Molina-Infante, J. P. Gisbert, and C. O’Morain, Helicobacter., 18, 58 – 65 (2013).
E. Ierardi, A. Giangaspero, G. Losurdo, et al., J. Gastrointest. Liver., 23, 367 – 370 (2014).
R. Kataria and A. Khatkar, BMC Chem., 13 (2019).
Y. T. Lin, Y. I. Kwon, R. G. Labbe, and K. Shetty, Appl. Environ. Microb., 71, 8558 – 8564 (2005).
Y. C. Wang, World. J. Gastroenterol., 20, 10368 – 10382 (2014).
J. T. Zhou, C. L. Li, L. H. Tan, et al., PloS. One., 12 (2017).
T. M. N. Luong, J. K. Moon, T. Shibamoto, and Y. J. Ahn, J. Agr. Food. Chem., 60, 9062 – 9073 (2012).
J. M. B. Vitor and F. F. Vale, Fems. Immunol. Med. Mic., 63, 153 – 164 (2011).
C. Kantar, N. Baltas, S. A. Karaoglu, and S. Sasmaz, Rev. Roum. Chim., 63, 189 – 197 (2018).
M. R. Maurya, A. Kumar, A. R. Bhat, et al., Inorg. Chem., 45, 1260 – 1269 (2006).
F. Niu, K. X. Yan, L. H. Pang, et al., Inorg. Chim. Acta., 435, 299 – 304 (2015).
Z. L. You, Y. Lu, N. Zhang, B. W. Ding, et al., Polyhedron, 30, 2186 – 2194 (2011).
Z. L. You, H. Sun, B. W. Ding, et al., J. Coord. Chem., 64, 3510 – 3520 (2011).
Y. M. Cui, Y. G. Li, Y. J. Cai, et al., J. Coord. Chem., 64, 610 – 616 (2011).
Y. M. Cui, W. X. Yan, Y. J. Cai, et al., J. Coord. Chem., 63, 3706 – 3713 (2010).
Z. L. You, M. Y. Liu, C. F. Wang, et al., RSC Adv., 6, 16679 – 16690 (2016).
A. Golcu, M. Tumer, H. Demirelli, and R. A. Wheatley, Inorg. Chim. Acta, 358, 1785 – 1797 (2005).
K. Singh, M. S. Barwa and P. Tyagi, Eur. J. Med. Chem., 41, 147 – 153 (2006).
K. M. Hijas, S. M. Kumar, K. Byrappa, et al., J. Mol. Struc., 1155, 249 – 259 (2018).
Z. D. Petrovic, J. Dorovic, D. Simijonovic, et al., RSC Adv., 5, 24094 – 24100 (2015).
N. Singh and P. S. Sethi, Int. J. Chem., 13, 990 – 991 (1975).
R. Apak, S. Gorinstein, V. Bohm, et al., J. Appl. Chem., 85, 957 – 998 (2013).
W. Brand-Williams, M. E. Cuvelier and C. Berset, Food Sci. Technol.-Leb., 28, 25 – 30 (1995).
R. Re, N. Pellegrini, A. Proteggente, et al., Free Rad. Bio. Med., 26, 1231 – 1237 (1999).
C. Kantar, N. Baltas, S. A. Karaoglu, and S. Sasmaz, Pharm. Chem. J., 55, 246 – 252 (2021).
A. Simiæ, D. Manojloviæ, D. Šegan, and M. Todoroviæ, Molecules, 12, 2327 (2007).
J. Y. Lee and K. S. Park, Gastro Res. Prac., 2016, 9086581 (2016).
M. Mitra, M. Asad, S. Kumar, et al., J. Phys. Chem. Lett., 10, 754 – 760 (2019).
Acknowledgments
This study was supported by the Recep Tayyip Erdoğan University Scientific Research Project Units (Project No: FBA-2020-1107).
Conflict of Interest Statement
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kantar, C., Baltaş, N., Karaoğlu, Ş.A. et al. Some Schiff Bases Containing Eugenol and Guaiacol: Comparison of Urease Inhibition and Anti-Helicobacter pylori Activities with Its Azo Analogs. Pharm Chem J 57, 1738–1744 (2024). https://doi.org/10.1007/s11094-024-03074-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-024-03074-5